| BCSFX | OSMYX | BCSFX / OSMYX | |
| Total Expense Ratio | 1.06 | 1.18 | 90% |
| Annual Report Gross Expense Ratio | 1.06 | 1.18 | 90% |
| Fund Existence | 11 years | 21 years | - |
| Gain YTD | -8.527 | 6.279 | -136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 1000 | 50,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 689M | 2.39B | 29% |
| Annual Yield % from dividends | 0.87 | 1.62 | 54% |
| Returns for 1 year | -19.07 | -8.82 | 216% |
| Returns for 3 years | 0.68 | -7.83 | -9% |
| Returns for 5 years | -20.43 | -36.45 | 56% |
| Returns for 10 years | 92.51 | 5.44 | 1,700% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PSTAX | 20.03 | 0.24 | +1.21% |
| Virtus KAR Capital Growth A | |||
| OMSYX | 33.99 | 0.28 | +0.83% |
| Invesco Main Street All Cap Y | |||
| DURPX | 29.56 | -0.05 | -0.17% |
| DFA US Hi Relatv Profitability Instl | |||
| MAGRX | 36.72 | -0.31 | -0.84% |
| BlackRock Natural Resources Instl | |||
| PHPIX | 44.67 | -1.83 | -3.94% |
| ProFunds Pharmaceuticals UltraSector Inv | |||